Hospital costs versus drug spending

It is no secret that pharmaceutical companies are being blamed left, right and center for rising healthcare costs. A series of high-profile cases, including Turing Pharmaceuticals’ 5,000% price increase of its Toxoplasmosis drug, Daraprim, and [...]

By |2021-03-15T11:32:51+00:00April 14th, 2017|Big Pharma|

OPEN Act is reintroduced in the US

This week, Rare Disease Day 2017 was celebrated in over 90 countries around the world, to help raise awareness of the 350 million people currently living with a rare disease. In honor of this day, [...]

By |2021-03-15T11:41:40+00:00March 3rd, 2017|Big Pharma|

What will Brexit mean for healthcare in the UK?

Since Britain voted to leave the EU, there has been much speculation on how this decision will affect the pharmaceutical industry and healthcare system within the country. Proponents of Brexit remain optimistic. However, there are [...]

By |2021-03-15T11:42:07+00:00February 16th, 2017|Big Pharma|

Adaptive Pathways

For many patients in the US, the passing of the 21st Century Cures Act was a great success. This new law will allow Real World Data (RWD) and patient experiences to be to be included [...]

By |2021-03-15T11:42:22+00:00February 8th, 2017|Big Pharma|
Go to Top